Total pharmaceutical sales in Sweden during February–July 2009 were EUR 1,397 (1,514) million in pharmacy purchase prices (PPP). In local currency, this represents an increase of 3.8% compared to the same period in the previous year.
Tamro Sweden’s net sales during February–July were EUR 717 (767) million. In local currency, the sales increased by 8.4% due to a major new supply contract. The company’s average market share rose to 55%. Tamro Sweden employed an average of 451 (459) people.
A new market situation is expected in Sweden once the pharmacy deregulation is finalised in late autumn. Due to the changes, the outlook for the full year 2009/10 cannot be forecasted.
